What Is GLP-1 and Why Is Everyone Talking About It?

It's not just a drug. It's a hormone your body already makes.

You've heard the name. But probably not the whole story. Ozempic is everywhere — in your news feed, in your group chat, maybe already in someone's medicine cabinet at your next dinner party. But most of the conversation skips the part that actually matters. GLP-1 isn't some pharmaceutical invention cooked up in a lab. It's a hormone your body has been producing your entire life. The medications work because they amplify something your biology was already trying to do. That's not marketing language. It changes how you think about this entire class of drugs.

Your gut has been doing this all along

GLP-1 stands for glucagon-like peptide-1. Every time you eat, specialized cells lining your small intestine release it into your bloodstream. Within minutes it's doing four things at once:

• Signaling your pancreas to release insulin, which moves sugar from your blood into your cells for energy.
• Telling your liver to stop releasing stored glucose, so blood sugar doesn't spike after a meal.
• Slowing the rate food moves from your stomach into your small intestine, which smooths out the blood sugar curve.
• Traveling to your brain and activating receptors that register fullness — the signal that says: okay, that's enough.

When the fullness signal gets quieter

In a healthy system this works beautifully. You eat, GLP-1 rises, blood sugar is managed, you feel satisfied, you stop eating. The whole thing happens quietly in the background without you ever thinking about it. In people with obesity, this system is often dysregulated. The gut doesn't release as much. The receptors don't respond as strongly. It gets broken down too quickly. The fullness signal gets quieter. Blood sugar is harder to control. The medications don't introduce something foreign. They amplify a signal your body was already trying to send — just louder and for longer than your body can manage on its own. GLP-1 isn't a drug invented in a lab. It's something your body already makes. The medications just turn up the volume on a signal that's been getting drowned out.

The food noise thing nobody talks about

Here's the part that gets left out of most coverage. GLP-1 receptors exist throughout the brain — in the hypothalamus which regulates hunger, in the brainstem which processes gut signals, and in the reward circuitry that drives the desire to eat in the first place. A lot of people with obesity experience what researchers now call food noise: near-constant mental chatter about food. Thinking about what to eat next while still eating. Feeling pulled toward the kitchen without real physical hunger. A background commentary that just never quite goes quiet. When GLP-1 receptors are activated in the brain, that chatter quiets. For many people, dramatically. Not just less hungry, but less mentally preoccupied with food in a way that can feel almost disorienting at first, because it's so unfamiliar.

Why is this a moment?

GLP-1 medications have existed since 2005, but earlier versions were modest. What changed was the newer generation, starting with semaglutide and then tirzepatide, which activated receptors more powerfully and for far longer. Clinical trials showed average weight loss of 15 to 21 percent of body weight. Previous weight loss medications typically produced 5 to 8 percent. The new generation nearly tripled that. Numbers like that spread fast.

• ~15% average weight loss with high-dose semaglutide (STEP 1 trial, NEJM 2021)
• ~21% average weight loss with tirzepatide (SURMOUNT-1 trial, NEJM 2022)
• ~70 million Americans estimated to meet GLP-1 candidacy criteria

What these medications are not

Understanding what GLP-1 medications can't do is just as important as understanding what they can.

• They're not magic. People who don't adjust eating habits see smaller results. The medication creates a window — what you do in that window still matters.
• They're not a permanent fix without ongoing use. Most people regain significant weight after stopping. This reflects obesity as a chronic condition, not a temporary problem to be solved.
• They're not without side effects. Nausea, constipation, and digestive discomfort are common early on and usually improve as your body adjusts.
• They're not for everyone. There are candidacy criteria and medical contraindications that a licensed clinician should evaluate before prescribing.

At Coivas

GLP-1 medications work best when prescribed after a real evaluation, not a five-minute online quiz. At Coivas, our providers take time to understand your health history, your goals, and whether this is genuinely the right fit for you. We offer compounded GLP-1 medications through licensed compounding pharmacies, prescribed by providers who know both the science and your situation.